StockData
Fortive Corp logo

Fortive Corp (FTV) stock analysis

FTVNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Oct 2, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3011% below fair value
$67.73+0.63 (+0.94%)

Close on Nov 10, 2026Market cap $20.16BP/E 32.3Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value3Growth1Performance2Health4Dividend4

Mixed14 of 30 checks passed

Fortive passes 14 of the 30 checks behind our score; 2 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
3/6
Growth
1/6
Past performance
2/6
Financial health
4/6
Dividend
4/6

What stands out

  • Trading below fair value

    The share price of $67.73 is below our fair value estimate of $76.47.

  • Interest well covered

    No meaningful interest expense to cover.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 34.2% of total debt.

  • Low bankruptcy risk

    The Altman Z-score is 3.55; above 3 is the safe zone and below 1.8 the distress zone.

What to watch

  • Margin of safety under 20%

    The price is 11.4% below fair value, less than the 20% cushion we look for.

  • Return on equity under 15%

    Return on equity was 10.5% over the last twelve months and averaged 7.9% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 8.3%, below the 10% that usually covers the cost of capital.

  • High debt

    Debt is 59.1% of shareholders' equity, above the 40% we consider low.

Valuation3/6
  • P/E above its 5-year median

    Fortive's P/E of 32.3 is above its own 5-year median of 31.8.

  • P/E below the industry

    Fortive's P/E of 32.3 is below the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 36.5.

  • EV/EBITDA below its 5-year median

    Fortive's EV/EBITDA of 17.7 is below its 5-year median of 27.2.

  • P/B above the industry

    Fortive's price-to-book of 3.39 is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 3.17.

  • Trading below fair value

    The share price of $67.73 is below our fair value estimate of $76.47.

  • Margin of safety under 20%

    The price is 11.4% below fair value, less than the 20% cushion we look for.

Growth1/6
  • Revenue growing under 10% a year

    Revenue grew -10.6% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -6.3% a year over the last three fiscal years.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew 7.0% over the last twelve months; the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median is 8.4%.

  • Guidance raised

    Fortive raised its FY 2026 adjusted diluted earnings per share outlook on Oct 28, 2026.

  • Gross margin slipping

    Gross margin was 63.5% over the last twelve months, against 63.9% a year earlier.

Past performance2/6
  • Return on equity under 15%

    Return on equity was 10.5% over the last twelve months and averaged 7.9% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 8.3%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Fortive's return on equity of 10.5% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of 1.1%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was 14.8% over the last twelve months, against a 5-year average of 17.4%.

  • Net margin above the industry

    Fortive's net margin of 14.8% is above the Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median of -1.3%.

Financial health4/6
  • High debt

    Debt is 59.1% of shareholders' equity, above the 40% we consider low.

  • Debt rising against equity

    Debt to equity rose from 47.2% five years ago to 59.1%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 34.2% of total debt.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term assets cover short-term debts

    Current assets are 1.23 times current liabilities.

  • Low bankruptcy risk

    The Altman Z-score is 3.55; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    Fortive paid dividends worth 0.4% of the share price over the last twelve months.

  • Yield below Treasuries

    The 0.4% yield is below the 4.4% on a 1-year Treasury.

  • Yield below the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Fortive yields 0.4%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 7 fiscal years.

  • Covered by earnings

    Dividends take 11.7% of net income.

  • Covered by free cash flow

    Dividends take 7.0% of free cash flow.

Scores of similar companies

Our estimate per share

$76.47

The share price is 11% below this estimate.

20%+ below
Near fair value
20%+ above
$67.73Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E34.2×31.8×36.5×$71.7240%
EV/EBITDA25.5×27.2×23.7×$101.9435%
P/B2.8×2.5×3.2×$56.8510%
Earnings power9.7% cost of equity––$42.8115%
Fair value$76.47100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 31.8
  • Laboratory Apparatus and Analytical, Optical, Measuring, and Controlling Instruments median 36.5

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$180.59M
Value traded per 1% price move
$113.60M

Downside

Low risk

Typical loss in a bad month
9.3%
Volatility (annualized)
28%
Sharpe ratio, 1 year
1.01
Beta to the S&P 500 (5Y)
0.96

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2013 to 2025

Gross margin

63.5%+7.2 pts over 5 years

Operating margin

17.3%+5.7 pts over 5 years

Net margin

13.9%

See a number that looks wrong?